Frontlight ResearchEarly access
Trial site
Japanese Red Cross Musashino Hospital
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- High blood pressure1 trial
- Mild cognitive impairment1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 34 trials
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Eli Lilly and Company2 trials
- Biogen1 trial
- Eisai Inc.1 trial
- Otsuka Medical Devices Co., Ltd. Japan1 trial
Running trials
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Peripheral artery disease1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026